XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIENCY) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Apr. 30, 2022   13,522,441      
Beginning balance (in shares) at Apr. 30, 2022     0    
Beginning balance at Apr. 30, 2022 $ 9,096 $ 14 $ 0 $ 81,064 $ (71,982)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 206     206  
Net loss (319)       (319)
Ending balance (in shares) at Jul. 31, 2022   13,522,441      
Ending balance (in shares) at Jul. 31, 2022     0    
Ending balance at Jul. 31, 2022 8,983 $ 14 $ 0 81,270 (72,301)
Beginning balance (in shares) at Apr. 30, 2022   13,522,441      
Beginning balance (in shares) at Apr. 30, 2022     0    
Beginning balance at Apr. 30, 2022 9,096 $ 14 $ 0 81,064 (71,982)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,774)        
Ending balance (in shares) at Jan. 31, 2023   13,558,650      
Ending balance (in shares) at Jan. 31, 2023     0    
Ending balance at Jan. 31, 2023 7,064 $ 14 $ 0 81,806 (74,756)
Beginning balance (in shares) at Jul. 31, 2022   13,522,441      
Beginning balance (in shares) at Jul. 31, 2022     0    
Beginning balance at Jul. 31, 2022 8,983 $ 14 $ 0 81,270 (72,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 119     119  
Issuance of common stock on exercise of stock options (in shares)   36,209      
Issuance of common stock on exercise of stock options 86     86  
Net loss (16)       (16)
Ending balance (in shares) at Oct. 31, 2022   13,558,650      
Ending balance (in shares) at Oct. 31, 2022     0    
Ending balance at Oct. 31, 2022 9,172 $ 14 $ 0 81,475 (72,317)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 331     331  
Net loss (2,439)       (2,439)
Ending balance (in shares) at Jan. 31, 2023   13,558,650      
Ending balance (in shares) at Jan. 31, 2023     0    
Ending balance at Jan. 31, 2023 $ 7,064 $ 14 $ 0 81,806 (74,756)
Beginning balance (in shares) at Apr. 30, 2023 13,544,228 13,544,228      
Beginning balance (in shares) at Apr. 30, 2023     14,422    
Beginning balance at Apr. 30, 2023 $ 4,636 $ 14 $ (74) 82,013 (77,317)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 423     423  
Issuance of common stock on exercise of stock options (in shares)   40,897      
Issuance of common stock on exercise of stock options 12     12  
Repurchase of common stock (in shares)   (101,015) 101,015    
Repurchase of common stock (602)   $ (602)    
Net loss (2,566)       (2,566)
Ending balance (in shares) at Jul. 31, 2023   13,484,110      
Ending balance (in shares) at Jul. 31, 2023     115,437    
Ending balance at Jul. 31, 2023 $ 1,903 $ 14 $ (676) 82,448 (79,883)
Beginning balance (in shares) at Apr. 30, 2023 13,544,228 13,544,228      
Beginning balance (in shares) at Apr. 30, 2023     14,422    
Beginning balance at Apr. 30, 2023 $ 4,636 $ 14 $ (74) 82,013 (77,317)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (7,167)        
Ending balance (in shares) at Jan. 31, 2024 13,593,766 13,593,766      
Ending balance (in shares) at Jan. 31, 2024     120,333    
Ending balance at Jan. 31, 2024 $ (2,058) $ 14 $ (708) 83,120 (84,484)
Beginning balance (in shares) at Jul. 31, 2023   13,484,110      
Beginning balance (in shares) at Jul. 31, 2023     115,437    
Beginning balance at Jul. 31, 2023 1,903 $ 14 $ (676) 82,448 (79,883)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 53     53  
Issuance of common stock on exercise of stock options (in shares)   114,552      
Issuance of common stock on exercise of stock options 240     240  
Repurchase of common stock (in shares)   4,896 4,896    
Repurchase of common stock (32)   $ (32)    
Net loss (2,071)       (2,071)
Ending balance (in shares) at Oct. 31, 2023   13,593,766      
Ending balance (in shares) at Oct. 31, 2023     120,333    
Ending balance at Oct. 31, 2023 93 $ 14 $ (708) 82,741 (81,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 379     379  
Net loss $ (2,530)       (2,530)
Ending balance (in shares) at Jan. 31, 2024 13,593,766 13,593,766      
Ending balance (in shares) at Jan. 31, 2024     120,333    
Ending balance at Jan. 31, 2024 $ (2,058) $ 14 $ (708) $ 83,120 $ (84,484)